GBP1 promotes erlotinib resistance via PGK1‑activated EMT signaling in non‑small cell lung cancer

Lifang Cheng(Southern Medical University), Jian Zhang(The First Affiliated Hospital, Sun Yat-sen University)
International Journal of Oncology
June 22, 2020
Cited by 44


Related Papers